Page last updated: 2024-08-21

pyrazines and Alveolar Bone Atrophy

pyrazines has been researched along with Alveolar Bone Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SY; Kim, HJ; Kim, JY; Kim, YG; Kwon, TG; Lee, HJ; Lee, JH; Lee, Y; Pokhrel, NK	1

Other Studies

1 other study(ies) available for pyrazines and Alveolar Bone Atrophy

Article	Year
A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide-induced alveolar bone resorption. Journal of periodontology, 2019, Volume: 90, Issue:5 Topics: Agammaglobulinaemia Tyrosine Kinase; Alveolar Bone Loss; Animals; Benzamides; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Lipopolysaccharides; Mice; NFATC Transcription Factors; Osteoclasts; Porphyromonas gingivalis; Pyrazines; RANK Ligand	2019

Article

Year

A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide-induced alveolar bone resorption.

Journal of periodontology, 2019, Volume: 90, Issue:5

Topics: Agammaglobulinaemia Tyrosine Kinase; Alveolar Bone Loss; Animals; Benzamides; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Lipopolysaccharides; Mice; NFATC Transcription Factors; Osteoclasts; Porphyromonas gingivalis; Pyrazines; RANK Ligand

2019